Clinical Trials Directory

Trials / Completed

CompletedNCT01417715

Endomicroscopy for Assessment of Mucosal Healing

Advanced Endoscopic Imaging Using Endomicroscopy for Assessment of Mucosal Healing in IBD

Status
Completed
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Inflammatory bowel disease (IBD) encompasses two major forms of chronic intestinal disorders, Crohn's disease and ulcerative colitis (UC). Diagnosis is based on several macroscopic and histologic features including patterns of inflammation, crypt abscesses and granulomas. Confocal laser endomicroscopy (CLE) is rapidly emerging as a valuable tool for gastrointestinal endoscopic imaging, enabling the endoscopist to obtain an "optical biopsy" of the gastrointestinal mucosa during the endoscopic procedure. The main objective of this study is to determine endomicroscopic features of mucosal healing in patients with IBD.

Conditions

Interventions

TypeNameDescription
DEVICEEndomicroscopyPatients will undergo advanced endoscopic imaging using endomicroscopy. Findings will be compared to histopathological and clinical results.

Timeline

Start date
2011-08-01
Primary completion
2014-05-01
Completion
2014-08-01
First posted
2011-08-16
Last updated
2020-12-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01417715. Inclusion in this directory is not an endorsement.